Literature DB >> 30248054

Age-Dependent Decrease of Mitochondrial Complex II Activity in a Familial Mouse Model for Alzheimer's Disease.

Tim L Emmerzaal1, Richard J Rodenburg2, Heikki Tanila3, Vivienne Verweij1, Amanda J Kiliaan1, Tamas Kozicz1,4.   

Abstract

Alzheimer's disease (AD) is a severe neurodegenerative disorder for which the exact etiology is largely unknown. An increasingly recognized and investigated notion is the pathogenic role of mitochondrial dysfunction in AD. We assessed mitochondrial oxidative-phosphorylation (OXPHOS) enzyme activities in the APPswe/PS1ΔE9 mouse model from 4.5 to 14 months of age. We show an age-dependent decrease in mitochondrial complex-II activity starting at 9 months in APP/PS1 mice. Other enzymes of the OXPHOS do not show any alterations. Since amyloid-β (Aβ) plaques are already present from 4 months of age, mitochondrial dysfunction likely occurs downstream of Aβ pathology in this mouse model.

Entities:  

Keywords:  Alzheimer’s disease; amyloid beta-peptides; electron transport complex II; electron transport complex IV; mice; mitochondria

Mesh:

Substances:

Year:  2018        PMID: 30248054     DOI: 10.3233/JAD-180337

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

1.  Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.

Authors:  Loan Vaillant-Beuchot; Arnaud Mary; Raphaëlle Pardossi-Piquard; Alexandre Bourgeois; Inger Lauritzen; Fanny Eysert; Paula Fernanda Kinoshita; Julie Cazareth; Céline Badot; Konstantina Fragaki; Renaud Bussiere; Cécile Martin; Rosanna Mary; Charlotte Bauer; Sophie Pagnotta; Véronique Paquis-Flucklinger; Valérie Buée-Scherrer; Luc Buée; Sandra Lacas-Gervais; Frédéric Checler; Mounia Chami
Journal:  Acta Neuropathol       Date:  2020-10-20       Impact factor: 17.088

2.  Activation of ERK-Drp1 signaling promotes hypoxia-induced Aβ accumulation by upregulating mitochondrial fission and BACE1 activity.

Authors:  Yuan Yuan; Jingjiong Chen; Xuhua Ge; Jiangshan Deng; Xiaofeng Xu; Yuwu Zhao; Hongmei Wang
Journal:  FEBS Open Bio       Date:  2021-08-27       Impact factor: 2.693

Review 3.  Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.

Authors:  Steven N Austad; Scott Ballinger; Thomas W Buford; Christy S Carter; Daniel L Smith; Victor Darley-Usmar; Jianhua Zhang
Journal:  Acta Pharm Sin B       Date:  2021-06-30       Impact factor: 11.413

4.  Mitochondrial Transfusion Improves Mitochondrial Function Through Up-regulation of Mitochondrial Complex II Protein Subunit SDHB in the Hippocampus of Aged Mice.

Authors:  A Adlimoghaddam; T Benson; B C Albensi
Journal:  Mol Neurobiol       Date:  2022-07-14       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.